Investigación

Biología molecular y regulación génica del tejido adiposo y sus patologías

Buscador de publicaciones

Publicaciones

  • Barroso, Sergio, Guitart-Mampel, Mariona, Garcia-Garcia, Francesc Josep, Canto-Santos, Judith, Valls-Roca, Laura, Andujar-Sanchez, Felix, Vilaseca-Capel, Adria, Tobias, Ester, Arias-Dimas, Angela, Quesada-Lopez, Tania, Artuch-Iriberri R, Villarroya-Gombau F, Giralt, Marta, Martinez, Esteban, Lozano, Ester and Garrabou, Gloria.

    Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 25(15): .

    [doi:10.3390/ijms25158418]

  • Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.

    SIRT1 regulates hepatic vldlr levels

    CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de citas: 1

    [doi:10.1186/s12964-024-01666-y]

  • Fernández-García P, Taxerås SD, Reyes-Farias M, González L, Soria-Gondek A, Pellitero S, Tarascó J, Moreno P, Sumoy L, Stephens JM, Yoo LG, Galán M, Izquierdo A, Medina-Gómez G, Herrero L, Corrales P, Villarroya-Gombau F, Cereijo R and Sánchez-Infantes D.

    Claudin-1 as a novel target gene induced in obesity and associated to inflammation, fibrosis and cell differentiation.

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 190(3): 201-210.

    [doi:10.1093/ejendo/lvae018]

  • Jurado-Fasoli L, Sanchez-Delgado G, Di X, Yang W, Kohler I, Villarroya-Gombau F, Aguilera CM, Hankemeier T, Ruiz JR and Martinez-Tellez B.

    Cold-induced changes in plasma signaling lipids are associated with a healthier cardiometabolic profile independently of brown adipose tissue.

    CELL REPORTS MEDICINE . 5(2): 101387-101387. Nº de citas: 2

    [doi:10.1016/j.xcrm.2023.101387]

  • Castellá M, Mestres-Arenas A, Gavaldà-Navarro A, Blasco-Roset A, Quesada T, Romero-Carramiñana I, Giralt M, Villarroya-Gombau F and Cereijo R.

    The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation

    BIOCHEMICAL PHARMACOLOGY . 220: 116014-116014. Nº de citas: 3

    [doi:10.1016/j.bcp.2023.116014]

  • Quesada T, Cereijo R, Blasco-Roset A, Mestres-Arenas A, Prieto P, Domingo JC, Villarroya-Gombau F, Domingo P and Giralt M.

    Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function

    BIOCHEMICAL PHARMACOLOGY . 220: 116010-116010. Nº de citas: 2

    [doi:10.1016/j.bcp.2023.116010]

  • Oliveras-Cañellas N, Moreno-Navarrete JM, Lorenzo PM, Garrido-Sánchez L, Becerril S, Rangel O, Latorre J, de la Calle Vargas E, Pardo M, Valentí V, Romero-Cabrera JL, Oliva-Olivera W, Silva C, Diéguez C, Villarroya-Gombau F, López M, Crujeiras AB, Seoane LM, López-Miranda J, Frühbeck G, Tinahones FJ and Fernández-Real JM.

    Downregulated adipose tissue expression of browning genes with increased environmental temperatures.

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 109(1): .

    [doi:10.1210/clinem/dgad469]

  • Díaz-Silva M, Casano-Sancho P, Quesada T, Lopez-Bermejo A, de Zegher F, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat

    Frontiers in Endocrinology . 14: 1257768-1257768.

    [doi:10.3389/fendo.2023.1257768]

  • Morón S, Blasco-Roset A, Navarro-Gascon A, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Uriarte I, Fernández-Barrena MG, Avila M, Ferrer-Curriu G, Lupón J, Bayés-Genis A, Villarroya-Gombau F, Gavaldà-Navarro A and Planavila A.

    A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy.

    JOURNAL OF PATHOLOGY . 261(3): 335-348. Nº de citas: 2

    [doi:10.1002/path.6193]

  • Curriu GF, Rued F, López ER, García CG, Codina P, Montón CG, Roura S, Aimo A, Emdin M, Planavila A and Genís AB.

    Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI.

    REVISTA ESPANOLA DE CARDIOLOGIA . 76(11): 891-900. Nº de citas: 4

    [doi:10.1016/j.rec.2023.03.015]